Zane Ellen M (CIK 1369850) reported 20 SEC Form 4 insider transactions across 3 companies over the past 18 months (most recent 2026-07-02). Recent activity: Buy SYF (789 shares), Buy SYF (14 shares), Buy BSX (3,800 shares), Buy SYF (883 shares), Buy SYF (14 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-02 | Synchrony Financial (SYF) | Director | Buy | 789 | $60,003 |
| 2026-05-19 | Synchrony Financial (SYF) | Director | Buy | 14 | $999 |
| 2026-05-11 | BOSTON SCIENTIFIC CORP (BSX) | Director | Buy | 3,800 | $0 |
| 2026-04-02 | Synchrony Financial (SYF) | Director | Buy | 883 | $60,062 |
| 2026-02-19 | Synchrony Financial (SYF) | Director | Buy | 14 | $1,012 |
| 2026-01-05 | Synchrony Financial (SYF) | Director | Buy | 660 | $55,064 |
| 2025-11-19 | Synchrony Financial (SYF) | Director | Buy | 15 | $1,057 |
| 2025-11-06 | BOSTON SCIENTIFIC CORP (BSX) | Director | Sell | 12,891 | $1.3M |
| 2025-10-31 | BOSTON SCIENTIFIC CORP (BSX) | Director | Buy | 12,891 | $0 |
| 2025-10-28 | BOSTON SCIENTIFIC CORP (BSX) | Director | Sell | 9,990 | $1.0M |
| 2025-10-28 | BOSTON SCIENTIFIC CORP (BSX) | Director | Sell | 2,901 | $296,598 |
| 2025-10-02 | Synchrony Financial (SYF) | Director | Buy | 775 | $55,064 |
| 2025-08-19 | Synchrony Financial (SYF) | Director | Buy | 15 | $1,072 |
| 2025-07-25 | HAEMONETICS CORP (HAE) | Director | Buy | 2,693 | $0 |
| 2025-07-02 | Synchrony Financial (SYF) | Director | Buy | 825 | $55,060 |
| 2025-05-19 | Synchrony Financial (SYF) | Director | Buy | 17 | $1,028 |
| 2025-05-09 | BOSTON SCIENTIFIC CORP (BSX) | Director | Buy | 2,081 | $0 |
| 2025-04-02 | Synchrony Financial (SYF) | Director | Buy | 1,039 | $55,005 |
| 2025-02-24 | BOSTON SCIENTIFIC CORP (BSX) | Director | Sell | 13,586 | $1.4M |
| 2025-02-20 | Synchrony Financial (SYF) | Director | Buy | 13 | $849 |
Source: SEC Form 4 filings · as of 2026-07-02